Origo Biopharma raises 2,3M€ in Series Seed financing with the participation from Sabadell Asabys, XesGalicia and the founding shareholders

by Asabys Partners

Origo Biopharma has announced the closing of a €2,3 million Series Seed financing, with the participation from Sabadell Asabys, XesGalicia and the founding shareholders. The financing, led by Sabade...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

SICC Innvierte, a vehicle managed by CDT...

by CDTI Innovación

With a target size of €250 million, the fund aims to complete betwee...

Photos Stream